ZNF43抗体—艾普蒂

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using P09243(ZNF43 Antibody) at dilution 1/30. (Original magnification: ×200)    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human brain tissue using P09243(ZNF43 Antibody) at dilution 1/30. (Original magnification: ×200)    

  
  

**Background of ZNF43 Antibody**

The ZNF43 antibody is a research tool designed to detect and study the zinc finger protein 43 (ZNF43), a member of the Krüppel-associated box (KRAB) domain-containing zinc finger protein (ZNF) family. ZNF43 is encoded by the *ZNF43* gene in humans and is implicated in transcriptional regulation, chromatin remodeling, and epigenetic silencing through its interaction with repressive protein complexes. Structurally, ZNF43 contains multiple C2H2-type zinc finger motifs, which facilitate sequence-specific DNA binding, and a KRAB domain that recruits co-repressors like TRIM28/KAP1 to mediate gene silencing.

Research suggests ZNF43 plays roles in embryonic development, cellular differentiation, and tumor suppression. Dysregulation of ZNF43 has been associated with cancers, including colorectal and ovarian cancers, where it may act as a tumor suppressor by modulating oncogenic pathways or maintaining genomic stability. The ZNF43 antibody is widely used in techniques such as Western blotting, immunohistochemistry (IHC), and chromatin immunoprecipitation (ChIP) to investigate its expression, localization, and DNA-binding activities in various tissues or disease models.

Commercial ZNF43 antibodies are typically raised in hosts like rabbits or mice, targeting specific epitopes (e.g., N-terminal or C-terminal regions). Validation data, including knockout/knockdown controls, are essential to confirm specificity. Studying ZNF43 with such antibodies enhances understanding of its biological functions and potential therapeutic relevance in diseases linked to transcriptional dysregulation.